Hepatopancreatobiliary Carcinoma — Trials

Hepatopancreatobiliary Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,360
Recruiting: 790
Ph III recruiting: 74
Growth YoY: +10.6%
Industry share: 27%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (645)

clinicaltrialsPublishedShowing 1,701–1,728 of 1,728 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05534906	The Detection of Small Early Liver Cancer With Natural History Follow up(SELINA)	recruiting	—	250	University of OxfordOTHER	1	Sep 10, 2022	clinicaltrials
NCT05276037	Value of Negative 18FDG PET/CT in Milan Out, Up-to-seven in, HCC Transplant Candidates	recruiting	—	350	University of LiegeOTHER	1	Sep 1, 2022	clinicaltrials